DE59204543D1 - Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane. - Google Patents
Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane.Info
- Publication number
- DE59204543D1 DE59204543D1 DE59204543T DE59204543T DE59204543D1 DE 59204543 D1 DE59204543 D1 DE 59204543D1 DE 59204543 T DE59204543 T DE 59204543T DE 59204543 T DE59204543 T DE 59204543T DE 59204543 D1 DE59204543 D1 DE 59204543D1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- treatment
- diseases
- respiratory system
- chenodeoxycholic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title abstract 4
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 title abstract 3
- 229960001091 chenodeoxycholic acid Drugs 0.000 title abstract 2
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 title abstract 2
- 229960001661 ursodiol Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000002345 respiratory system Anatomy 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 201000001883 cholelithiasis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 229940054870 urso Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1452/91A CH680704A5 (enExample) | 1991-05-15 | 1991-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE59204543D1 true DE59204543D1 (de) | 1996-01-18 |
Family
ID=4210798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59204543T Expired - Fee Related DE59204543D1 (de) | 1991-05-15 | 1992-05-06 | Chenodeoxycholsäure oder Ursodeoxycholsäure zur Behandlung von Erkrankungen der Atmungsorgane. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5310560A (enExample) |
| EP (1) | EP0514328B1 (enExample) |
| JP (1) | JP2544868B2 (enExample) |
| AT (1) | ATE131060T1 (enExample) |
| CA (1) | CA2067863C (enExample) |
| CH (1) | CH680704A5 (enExample) |
| DE (1) | DE59204543D1 (enExample) |
| DK (1) | DK0514328T3 (enExample) |
| ES (1) | ES2079832T3 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0720854A1 (de) * | 1995-01-04 | 1996-07-10 | Medichemie Ag | Verwendung von Gallensäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen der Haut |
| DE19701264A1 (de) | 1997-01-16 | 1998-07-23 | Kief Lizenz Verwertungsgesells | Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische |
| KR100578669B1 (ko) * | 1997-05-29 | 2006-12-07 | 동아제약주식회사 | 우르소데옥시콜린산을함유하는투명연질캅셀 |
| US7772220B2 (en) * | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
| US20050158408A1 (en) * | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
| US7303768B2 (en) | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| RU2224523C2 (ru) | 1998-07-24 | 2004-02-27 | Сео Хонг Ю | Водный раствор, содержащий желчную кислоту, и способ его получения |
| AU5916900A (en) * | 1999-07-06 | 2001-01-22 | Nutricology, Inc. | Method for treatment of asthma syndrome |
| CN100558407C (zh) * | 2000-02-04 | 2009-11-11 | 柳署弘 | 制备含有胆汁酸的澄清水溶液剂型 |
| US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
| KR101414810B1 (ko) * | 2004-08-30 | 2014-07-18 | 주식회사 유스팜인터내셔널 | 국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과 |
| US20060074057A1 (en) * | 2004-10-04 | 2006-04-06 | Eric Marchewitz | Use of chenodeoxycholic acid for reducing adipose tissue |
| ATE506955T1 (de) * | 2004-10-15 | 2011-05-15 | Seo Hong Yoo | Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin |
| CA2585471A1 (en) * | 2004-11-01 | 2006-05-11 | Seo Hong Yoo | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| WO2022060121A1 (ko) * | 2020-09-18 | 2022-03-24 | 주식회사 아미코젠파마 | 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물 |
| KR102624174B1 (ko) * | 2020-09-18 | 2024-01-23 | 주식회사 아미코젠파마 | 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8417895D0 (en) * | 1984-07-13 | 1984-08-15 | Marples B A | Pharmaceutical anti-fungal composition |
| IT1212141B (it) * | 1987-06-03 | 1989-11-08 | So Ri Far S R L | Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare. |
-
1991
- 1991-05-15 CH CH1452/91A patent/CH680704A5/de not_active IP Right Cessation
-
1992
- 1992-04-30 JP JP4111589A patent/JP2544868B2/ja not_active Expired - Lifetime
- 1992-05-01 CA CA002067863A patent/CA2067863C/en not_active Expired - Fee Related
- 1992-05-05 US US07/879,339 patent/US5310560A/en not_active Expired - Lifetime
- 1992-05-06 DE DE59204543T patent/DE59204543D1/de not_active Expired - Fee Related
- 1992-05-06 EP EP92810330A patent/EP0514328B1/de not_active Expired - Lifetime
- 1992-05-06 ES ES92810330T patent/ES2079832T3/es not_active Expired - Lifetime
- 1992-05-06 AT AT92810330T patent/ATE131060T1/de not_active IP Right Cessation
- 1992-05-06 DK DK92810330.8T patent/DK0514328T3/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE131060T1 (de) | 1995-12-15 |
| DK0514328T3 (da) | 1996-02-12 |
| US5310560A (en) | 1994-05-10 |
| CH680704A5 (enExample) | 1992-10-30 |
| EP0514328A1 (de) | 1992-11-19 |
| CA2067863C (en) | 1997-12-30 |
| JP2544868B2 (ja) | 1996-10-16 |
| EP0514328B1 (de) | 1995-12-06 |
| ES2079832T3 (es) | 1996-01-16 |
| JPH0717867A (ja) | 1995-01-20 |
| CA2067863A1 (en) | 1992-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE131060T1 (de) | Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane. | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE195527T1 (de) | Neue steroidester zur behandlung von hauterkrankungen | |
| FI830958A7 (fi) | Koostumuksia terapeuttista tai diagnostista käyttöä varten ja terapeuttinen käsittelymenetelmä. | |
| DE69933208D1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| DE69731473D1 (de) | Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen | |
| ATE79544T1 (de) | Zusammensetzungen zur behandlung von hypercholesterinaemie. | |
| DE59711321D1 (de) | Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen | |
| ATE170077T1 (de) | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff | |
| UA37196C2 (uk) | Лікарська форма для перорального введення для лікування запальних хвороб кишкового тракту | |
| ATE71629T1 (de) | Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels. | |
| ATE91628T1 (de) | Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten. | |
| NO166939C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater. | |
| ATE203907T1 (de) | Dermatologische zubereitung zur behandlung von aktinischen keratosen | |
| ATE287719T1 (de) | Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge | |
| DE3878313D1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
| DE3685853D1 (de) | Mittel zur behandlung von knochenkrankheiten. | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
| ATE78168T1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
| DE68922688D1 (de) | Kombinierung von tobramycin und steroiden für topische ophthalmische verwendung. | |
| DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
| FR2600256B1 (fr) | Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus | |
| DE69829995D1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |